About 51,200 results
Open links in new tab
  1. Treatment-Free Remission: the New Goal in CML Therapy

    Treatment-free remission (TFR) is considered one of the main goals of therapy in patients with CML. Our goal in this paper is to review the current data on TFR, and discuss future directions. Multiple …

  2. The evolution of treatment-free remission | Blood | American ...

    Feb 27, 2025 · Introduction Treatment-free remission (TFR) is considered the ultimate goal of therapy for most patients with chronic phase chronic myeloid leukemia (CML). This enthusiasm is based …

  3. Mayo Clinic Q and A: Treatment-free remission for chronic ...

    Oct 30, 2024 · Dr. Kebede Begna explains treatment-free remission and the criteria for determining if the approach is appropriate for people with CML.

  4. Best Practices in Achieving Treatment-Free Remission in ...

    Oct 19, 2022 · Dr. Ehab Atallah Key Points: Tyrosine kinase inhibitor (TKI) discontinuation is associated with notable improvements in quality of life— improved fatigue, diarrhea and social function—as well …

  5. British Journal of Haematology | Wiley Online Library

    6 days ago · The modern management of chronic myeloid leukaemia (CML) identifies a new therapeutic goal of treatment-free remission (TFR). Half of CML patients in durable deep molecular response …

  6. Real World Outcomes with Treatment Free Remission in Chronic ...

    Real World Outcomes with Treatment Free Remission in Chronic Myeloid Leukemia-Experience from a Tertiary Care Cancer Centre.

  7. TKI discontinuation in CML: how do we make more patients ...

    Dec 10, 2021 · Treatment-free remission (TFR) is a new and significant goal of chronic myeloid leukemia management. TFR should be considered for patients in stable deep molecular response …

  8. Treatment-Free Remission in Chronic Myeloid Leukemia ... - PubMed

    Jun 25, 2025 · Chronic myeloid leukemia (CML) has undergone a transformation from a fatal disease to a chronic, manageable condition with the advent of tyrosine kinase inhibitors (TKIs), particularly …